Skip to content

002589.SZ

瑞康医药

SZSE · Healthcare · F 批发零售 · CN

CNY 3.02
−5.03%
Ask drillr
  • Aug 20, 2026, 12:26 UTC

    Ruikang Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 11.1353 million yuan, down 38.70% year-on-year.